Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Grapefruit USA, Inc. (GPFT)
USD0.00
0.00 (-33.33%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address
1000 Northwest Street 19801
Wilmington, DE, US
Wilmington, DE, US
CEO
Bradley J. Yourist
Website
grapefruitblvd.com
IPO
2016-06-23
CIK 1205181 ISIN US3885981049
Description
Grapefruit USA, Inc. is a company dedicated to the creation and distribution of cannabis-related goods, primarily serving the California market. A key offering from the firm is Hourglass, a topical cream featuring a sustained-release blend of THC and CBD, which is exclusively sold via its online platform. The business, originally established in 2017, was formerly recognized as Grapefruit Boulevard Investments, Inc., before officially adopting its current name, Grapefruit USA, Inc., in January 2020. Its main operational base is situated in Wilmington, Delaware.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
0.00 (-33.33%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
-0.09
Float Shares
460.08M
Free Float %
64.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -14.29% | -18.18% | +28.57% | +76.47% | +157.14% | +46.82% | +0.00% | -79.07% | -99.20% | -55.00% | -55.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-30.15
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
4 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%—
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+172.7% ★ Q1'26: +400.0% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%—
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%—
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%— Q1'26: +7.9% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+1.9% Q1'26: +5.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-21.85× Q1'26: -20.25× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-31.7K
OE per share TTM
0.00
Owner's Yield
-2.48%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
253.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Toronto Dominion Investments, Inc. | 128.00M | 100.00% | 11.67M | — | 11.67M | — | CO | USA | 2016-07-22 | ↗ |
| 2 | ( | 45.53M | 9.90% | — | 45.53M | — | — | IN | Cayman Islands | 2012-05-08 | ↗ |
| 3 | Master Fund, Ltd. | 19.73M | 9.90% | — | 19.73M | — | — | CO | Islands | 2016-07-05 | ↗ |
| 4 | Strategies LLC, Inc. | 19.73M | 9.90% | — | 19.73M | — | — | CO | Delaware | 2016-07-05 | ↗ |
| 5 | Winters | 19.73M | 9.90% | — | 19.73M | — | — | IN | States | 2016-07-05 | ↗ |
| 6 | Page 2 of 4 Pages | 15.51M | 9.90% | 15.51M | — | 15.51M | — | EP, IN | Liechtenstein | 2013-09-09 | ↗ |
| 7 | Gemini Master Fund, Ltd. | 15.26M | 9.90% | — | 15.26M | — | — | CO | Cayman Islands | 2013-09-11 | ↗ |
| 8 | Gemini Strategies LLC, Inc. | 15.26M | 9.90% | — | 15.26M | — | — | CO | Cayman Islands | 2013-09-11 | ↗ |
| 9 | Steven Winters | 15.26M | 9.90% | — | 15.26M | — | — | IN | Cayman Islands | 2013-09-11 | ↗ |
| 10 | BARCLAYS GLOBAL INVESTORS, NA. | 1.49M | 1.95% | 12.55M | — | 12.55M | — | BK | Delaware | 2013-09-12 | ↗ |
| 11 | Royal Bank of Canada | 371.00 | 6.40% | 15.29M | — | 15.29M | — | HC | USA | 2016-10-18 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
6
Shares acquired
—
Shares disposed
523.0K
Cash buys
—
Cash sales
6.00
Net activity
-523,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-04 | Yourist Bradley J | Officer | S-Sale | D | Common Stock | 23,000 | 0.02 | 508.30 | 129,275,426 | — | ↗ |
| 2022-03-03 | Yourist Daniel J. | Officer | S-Sale | D | Common Stock | 100,000 | 0.03 | 2.6K | 128,125,206 | — | ↗ |
| 2022-02-15 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.03 | 3.3K | 129,298,426 | — | ↗ |
| 2022-02-01 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.02 | 1.9K | 129,398,426 | — | ↗ |
| 2022-01-18 | Yourist Daniel J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.02 | 2.0K | 128,225,206 | — | ↗ |
| 2022-01-18 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.02 | 2.0K | 129,498,426 | — | ↗ |
| 2021-12-23 | Yourist Daniel J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.03 | 2.7K | 128,325,206 | — | ↗ |
| 2021-12-23 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.03 | 2.6K | 129,598,426 | — | ↗ |
| 2021-12-15 | Yourist Daniel J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.03 | 2.9K | 128,425,206 | — | ↗ |
| 2021-12-15 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.03 | 2.8K | 129,698,426 | — | ↗ |
| 2021-12-09 | Yourist Daniel J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 88,359 | 0.03 | 2.9K | 128,525,206 | — | ↗ |
| 2021-12-09 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.03 | 3.3K | 129,798,426 | — | ↗ |
| 2021-12-03 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 58,457 | 0.03 | 1.8K | 129,898,426 | — | ↗ |
| 2021-11-29 | Yourist Daniel J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 144,000 | 0.03 | 4.7K | 128,613,565 | — | ↗ |
| 2021-11-26 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.03 | 3.0K | 129,956,883 | — | ↗ |
| 2021-11-24 | Yourist Daniel J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 56,145 | 0.03 | 1.6K | 128,757,565 | — | ↗ |
| 2021-11-16 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 35,500 | 0.04 | 1.3K | 130,056,883 | — | ↗ |
| 2021-11-15 | Yourist Daniel J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.04 | 3.7K | 128,813,710 | — | ↗ |
| 2021-11-15 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 64,500 | 0.04 | 2.4K | 130,092,383 | — | ↗ |
| 2021-11-12 | Yourist Daniel J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.04 | 3.7K | 128,913,710 | — | ↗ |
| 2021-11-12 | Yourist Bradley J | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.04 | 3.6K | 130,156,883 | — | ↗ |
| 2021-05-17 | Yourist Daniel J. | Director / Officer / 10% Owner | A-Award | A | Common Stock | 4,321,314 | 0.11 | 475.3K | 134,304,882 | — | ↗ |
| 2021-05-17 | Yourist Bradley J | Director / Officer / 10% Owner | A-Award | A | Common Stock | 996,505 | 0.11 | 109.6K | 130,980,073 | — | ↗ |
| 2019-07-25 | Yourist Daniel J. | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 129,983,568 | — | ↗ |
| 2019-07-25 | Yourist Bradley J | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 129,983,568 | — | ↗ |
| 2017-04-26 | Medley Dane | Director / Officer | A-Award | A | Warrants | 36,000,000 | 0.02 | 720.0K | 37,395,000 | — | ↗ |
| 2017-04-26 | Aguilera Emilio Xavier | Director / Officer | A-Award | A | Warrants | 20,000,000 | 0.02 | 400.0K | 20,503,800 | — | ↗ |
| 2017-04-24 | Medley Dane | Director / Officer | J-Other | D | Common Stock | 18,000,000 | 0.00 | — | 1,395,000 | — | ↗ |
| 2017-04-24 | Aguilera Emilio Xavier | Director / Officer | J-Other | D | Common Stock | 10,000,000 | 0.00 | — | 503,800 | — | ↗ |
| 2016-07-20 | Medley Dane | Director / Officer | — | D | Dane Medley | 0 | 0.00 | — | 806,981 | — | ↗ |
| 2016-07-19 | Aguilera Emilio Xavier | Director / Officer | — | D | The Aguilera Family Trust E. Xavier Aguilera TTEE | 0 | 0.00 | — | 10,000,000 | — | ↗ |
| 2014-12-14 | Medley Dane | Director / Officer | — | D | Stock Options | 4,000,000 | 0.03 | 100.0K | 0 | — | ↗ |
| 2014-12-14 | Aguilera Emilio Xavier | Director / Officer | — | D | Stock Options | 4,000,000 | 0.03 | 100.0K | 0 | — | ↗ |
| 2011-06-09 | SOHN CHRISTOPHER | Director / Officer | J-Other | D | Common Stock | 3,300,000 | 0.19 | 632.0K | 19,700,000 | — | ↗ |
| 2010-02-12 | JANES DEAN | Director / Officer / 10% Owner | J-Other | D | Common Stock | 2,600,000 | 0.71 | 1.85M | 59,576,328 | — | ↗ |
| 2009-03-20 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 150,000 | 0.07 | 9.8K | 62,176,328 | — | ↗ |
| 2009-03-19 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 0.07 | 3.3K | 62,326,328 | — | ↗ |
| 2009-03-18 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 0.07 | 3.3K | 62,376,328 | — | ↗ |
| 2009-03-14 | JANES DEAN | Director / Officer / 10% Owner | J-Other | D | Common Stock | 32,238,131 | 5,973,194.00 | 192.56T | 27,338,197 | — | ↗ |
| 2009-03-06 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.07 | 1.3K | 62,426,328 | — | ↗ |
| 2009-03-05 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 0.06 | 3.0K | 62,446,328 | — | ↗ |
| 2009-03-04 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.06 | 1.2K | 62,496,328 | — | ↗ |
| 2009-02-27 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 80,000 | 0.06 | 4.9K | 62,516,328 | — | ↗ |
| 2009-02-26 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,000,000 | 0.06 | 60.0K | 62,596,328 | — | ↗ |
| 2009-02-25 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.06 | 1.2K | 63,596,328 | — | ↗ |
| 2009-02-24 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 105,000 | 0.06 | 6.3K | 63,616,328 | — | ↗ |
| 2009-02-23 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.06 | 1.2K | 63,721,328 | — | ↗ |
| 2009-02-20 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 30,000 | 0.06 | 1.8K | 63,741,328 | — | ↗ |
| 2009-02-18 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 30,000 | 0.07 | 2.0K | 63,771,328 | — | ↗ |
| 2008-12-23 | JANES DEAN | Director / Officer / 10% Owner | J-Other | D | Common Stock | 500,000 | 0.06 | 27.5K | 59,916,328 | — | ↗ |
| 2008-12-22 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 110,000 | 0.06 | 6.4K | 63,691,328 | — | ↗ |
| 2008-12-19 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 150,000 | 0.06 | 9.0K | 63,801,328 | — | ↗ |
| 2008-12-17 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 200,000 | 0.06 | 12.0K | 63,951,328 | — | ↗ |
| 2008-12-16 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.06 | 5.8K | 64,151,328 | — | ↗ |
| 2008-12-15 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 15,000 | 0.06 | 900.00 | 64,286,328 | — | ↗ |
| 2008-12-12 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 0.05 | 2.5K | 64,301,328 | — | ↗ |
| 2008-12-11 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.06 | 1.1K | 64,351,328 | — | ↗ |
| 2008-12-10 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 151,000 | 0.05 | 7.6K | 64,371,325 | — | ↗ |
| 2008-12-09 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 39,627 | 0.06 | 2.2K | 64,522,328 | — | ↗ |
| 2008-12-08 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.06 | 6.0K | 64,561,955 | — | ↗ |
| 2008-12-05 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 150,000 | 0.05 | 7.5K | 64,661,955 | — | ↗ |
| 2008-12-01 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 31,000 | 0.06 | 1.9K | 64,811,955 | — | ↗ |
| 2008-11-19 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 285,000 | 0.06 | 17.1K | 64,842,955 | — | ↗ |
| 2008-11-12 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 55,000 | 0.06 | 3.3K | 65,127,955 | — | ↗ |
| 2008-11-05 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,000 | 0.06 | 60.00 | 65,182,955 | — | ↗ |
| 2008-11-04 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 80,000 | 0.06 | 4.8K | 65,183,955 | — | ↗ |
| 2008-10-27 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 76,000 | 0.06 | 4.6K | 65,263,955 | — | ↗ |
| 2008-10-23 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 164,400 | 0.06 | 9.9K | 65,339,955 | — | ↗ |
| 2008-10-22 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 70,833 | 0.07 | 5.0K | 65,654,355 | — | ↗ |
| 2008-10-20 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | A | Common Stock | 15,000 | 0.06 | 900.00 | 65,725,188 | — | ↗ |
| 2008-10-17 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 78,500 | 0.06 | 4.7K | 65,740,188 | — | ↗ |
| 2008-10-16 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 210,000 | 0.06 | 12.7K | 65,818,688 | — | ↗ |
| 2008-10-15 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 142,172 | 0.07 | 9.6K | 66,028,688 | — | ↗ |
| 2008-07-09 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,000 | 0.11 | 2.8K | 66,170,861 | — | ↗ |
| 2008-06-30 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 26,050 | 0.11 | 2.9K | 66,195,861 | — | ↗ |
| 2008-06-27 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common stock | 5,000 | 0.11 | 550.00 | 66,221,911 | — | ↗ |
| 2008-06-23 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,600 | 0.11 | 176.00 | 66,226,911 | — | ↗ |
| 2008-06-20 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.11 | 2.2K | 66,228,511 | — | ↗ |
| 2008-05-28 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 29,000 | 0.11 | 3.2K | 66,248,511 | — | ↗ |
| 2008-05-27 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 170,000 | 0.11 | 18.7K | 66,277,511 | — | ↗ |
| 2008-05-23 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 0.11 | 5.7K | 66,447,511 | — | ↗ |
| 2008-05-22 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,400 | 0.11 | 484.00 | 66,497,511 | — | ↗ |
| 2008-05-21 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 0.11 | 5.5K | 66,501,911 | — | ↗ |
| 2008-05-19 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 165,000 | 0.11 | 18.2K | 66,551,911 | — | ↗ |
| 2008-05-16 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 225,000 | 0.11 | 24.8K | 66,716,911 | — | ↗ |
| 2008-05-15 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 60,000 | 0.11 | 6.6K | 66,941,911 | — | ↗ |
| 2008-05-13 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 85,000 | 0.11 | 9.4K | 67,001,911 | — | ↗ |
| 2008-05-10 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.12 | 2.4K | 66,983,211 | — | ↗ |
| 2008-05-09 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,700 | 0.12 | 324.00 | 67,003,211 | — | ↗ |
| 2008-05-08 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,000 | 0.12 | 120.00 | 67,005,911 | — | ↗ |
| 2008-05-04 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 80,000 | 0.12 | 9.6K | 67,006,911 | — | ↗ |
| 2008-04-25 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 29,500 | 0.12 | 3.5K | 67,086,911 | — | ↗ |
| 2008-04-24 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 30,000 | 0.11 | 3.3K | 67,116,411 | — | ↗ |
| 2008-04-10 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,600 | 0.13 | 858.00 | 67,146,411 | — | ↗ |
| 2008-04-07 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 371,000 | 0.12 | 44.5K | 67,158,311 | — | ↗ |
| 2008-03-26 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 15,000 | 0.12 | 1.8K | 67,529,011 | — | ↗ |
| 2008-03-25 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 33,300 | 0.13 | 4.2K | 67,544,011 | — | ↗ |
| 2008-03-24 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 0.13 | 12.5K | 67,577,311 | — | ↗ |
| 2008-03-20 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 83,000 | 0.13 | 10.4K | 67,677,311 | — | ↗ |
| 2008-03-19 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 124,000 | 0.13 | 15.5K | 67,760,311 | — | ↗ |
| 2008-03-18 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 98,800 | 0.12 | 12.1K | 67,884,311 | — | ↗ |
| 2008-03-17 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.13 | 1.3K | 67,983,111 | — | ↗ |
| 2008-03-11 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.13 | 1.3K | 67,993,111 | — | ↗ |
| 2008-03-10 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 35,000 | 0.13 | 4.4K | 68,003,111 | — | ↗ |
| 2008-03-07 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 80,000 | 0.13 | 10.0K | 68,048,111 | — | ↗ |
| 2008-03-06 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.14 | 2.7K | 68,128,111 | — | ↗ |
| 2008-03-05 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 10,200 | 0.13 | 1.3K | 68,198,111 | — | ↗ |
| 2008-03-03 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | COMMON STOCK | 10,000 | 0.13 | 1.3K | 68,208,311 | — | ↗ |
| 2008-02-28 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 67,500 | 0.14 | 9.3K | 68,218,311 | — | ↗ |
| 2008-02-27 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 50,000 | 0.14 | 6.8K | 68,285,811 | — | ↗ |
| 2008-02-22 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 70,000 | 0.15 | 10.5K | 68,335,811 | — | ↗ |
| 2008-02-21 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 30,000 | 0.16 | 4.7K | 68,405,811 | — | ↗ |
| 2008-02-20 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 28,670 | 0.15 | 4.3K | 68,435,811 | — | ↗ |
| 2008-02-19 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 142,500 | 0.15 | 21.4K | 68,512,500 | — | ↗ |
| 2008-02-15 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 30,000 | 0.14 | 4.2K | 68,675,000 | — | ↗ |
| 2008-02-14 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 80,000 | 0.14 | 11.2K | 68,705,000 | — | ↗ |
| 2008-02-13 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 30,000 | 0.14 | 4.2K | 68,785,000 | — | ↗ |
| 2008-02-12 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 5,000 | 0.15 | 750.00 | 68,815,000 | — | ↗ |
| 2008-02-11 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 31,000 | 0.16 | 5.0K | 68,820,000 | — | ↗ |
| 2008-02-09 | JANES DEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 0.16 | 775.00 | 68,846,000 | — | ↗ |
| 2008-02-08 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 10,000 | 0.16 | 1.6K | 68,940,000 | — | ↗ |
| 2008-02-07 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 15,000 | 0.16 | 2.3K | 68,960,000 | — | ↗ |
| 2008-02-06 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 10,000 | 0.17 | 1.7K | 68,975,000 | — | ↗ |
| 2008-02-05 | JANES DEAN | Officer | S-Sale | D | COMMON STOCK | 15,000 | 0.17 | 2.5K | 68,985,000 | — | ↗ |
| 2001-08-01 | SOHN CHRISTOPHER | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 23,000,000 | — | ↗ |
| 1999-07-15 | AGUILERA XAVIER | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 200,000 | — | ↗ |
| 1993-10-29 | JANES MICHELE | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
717.40M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bradley J. Yourist | Chairman of the Board, Chief Executive Officer & President | 180.0K | male |
| Daniel J. Yourist | Chief Operating Officer, Corporate Secretary & Director | 180.0K | male |
| Beth Jones | Chief Compliance Officer | — | — |
| Chantel Lee | Head of Sales & Marketing | — | — |
| Kenneth J. Biehl | Executive Vice President & Chief Financial Officer | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GPFT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
